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Aim: Abnormal daily sleep duration and quality have been linked to hypertension, diabetes, stroke,
and overall cardiovascular disease (CVD) morbidity& mortality. However, the relationship between
daily sleep duration and quality with subclinical measures of CVD remain less well studied. This systematic review evaluated how daily sleep duration and quality affect burden of subclinical CVD in
subjects free of symptomatic CVD.
Methods: Literature search was done via MEDLINE, EMBASE, Web of Science until June 2016 and
32 studies met the inclusion criteria. Sleep duration and quality were measured either via subjective
methods, as self-reported questionnaires or Pittsburg Sleep Quality Index (PSQI) or via objective
methods, as actigraphy or polysomnography or by both. Among subclinical CVD measures, coronary
artery calcium (CAC) was measured by electron beam computed tomography, Carotid intima-media
thickness (CIMT) measured by high-resolution B-mode ultrasound on carotid arteries, endothelial/
microvascular function measured by flow mediated dilation (FMD) or peripheral arterial tone (PAT)
or iontophoresis or nailfold capillaroscopy, and arterial stiffness measured by pulse wave velocity
(PWV) or ankle brachial index (ABI).
Results: Subjective short sleep duration was associated with CAC and CIMT, but variably associated
with endothelial dysfunction (ED) and arterial stiffness; however, subjective long sleep duration was
associated with CAC, CIMT and arterial stiffness, but variably associated with ED. Objective short
sleep duration was positively associated with CIMT and variably with CAC but not associated with
ED. Objective long sleep duration was variably associated with CAC and CIMT but not associated
with ED. Poor subjective sleep quality was significantly associated with ED and arterial stiffness but
variably associated with CAC and CIMT. Poor objective sleep quality was significantly associated
with CIMT, and ED but variably associated with CAC.
Conclusions: Overall, our review provided mixed results, which is generally in line with published
literature, with most of the studies showing a significant relationship with subclinical CVD, but only
some studies failed to demonstrate such an association. Although such mechanistic relationship
needs further evaluation in order to determine appropriate screening strategies in vulnerable populations, this review strongly suggested the existence of a relationship between abnormal sleep duration
and quality with increased subclinical CVD burden.
Key words: Sleep duration, Sleep quality, Subclinical cardiovascular disease, Coronary Artery Calcium
(CAC), Carotid intima media thickness (CIMT), Endothelial function, Flow Mediated
Dilation (FMD), Arterial stiffness, Pulse Wave Velocity (PWV)
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Introduction
A good hygienic sleep is an essential part of
everyday life. It is estimated that humans spend one
third of their lifetime sleeping. An estimated 50 – 70
million Americans suffer from sleep disorders, yet only
20% report it to their physicians 1). Poor sleep may be
a risk factor for cardiovascular disease (CVD) and has
serious biological consequences 2). A growing body of
literature suggests a relationship of sleep parameters
(sleep duration and sleep quality) with CVD, stroke,
and all-cause morbidity & mortality 3). A recent review
of 23 studies determined that both short and long
sleep is related to increased risk for all-cause mortality
among both men and women, compared to individuals who report a medium amount of daily sleep (7 – 8
hours) 4), however, some studies have shown that the
sleep disturbances may be associated with CVD mortality with weaker evidence for women 5). Additionally,
acute and chronic sleep deprivation can lead to weight
gain, impaired glucose tolerance, activate pro-inflammatory pathways, increased sympathetic activity and
higher cortisol levels in healthy subjects 6).
The epidemiological data suggests strong association of subjectively and/or objectively measured sleep
parameters with classical CVD risk factors like hypertension, insulin resistance, hypercholesterolemia, type
2 diabetes and increase in the inflammatory markers
leading to subclinical and clinical CVD 7-10). The traditional risk stratification has relied mainly on scoring
systems such as the Framingham risk score to determine the CVD risks 11). However, newer non-invasive
techniques that assess coronary artery calcium (CAC),
carotid intima-media thickness (CIMT), flow-mediated dilation (FMD), Ankle Brachial Index (ABI) and
pulse wave velocity (PWV) provide refined assessment
of early atherosclerosis process, endothelial dysfunction and arterial stiffness potentially leading to clinical
CVD events. The extent of CAC and CIMT correlates with plaque burden and atherosclerosis, decreased
FMD correlates with endothelial dysfunction, decreased
ABI but increased PWV measure increasing arterial
stiffness 12-15). There are some studies that show relationship of these non-invasive subclinical CVD markers with disturbed sleep parameters 16, 17) and signify
the importance of regular sleep habits but such relationships between the sleep parameters and subclinical
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CVD markers need to be studied in more detail. As
early recognition of subclinical CVD in people with
sleep disturbances may impact risk stratification and
early treatment of subclinical CVD before the development of clinical CVD events.
The purpose of this systematic review is to evaluate the following: First the relationship between selfreported or/and objectively assessed sleep duration
with markers of subclinical CVD. Second, the relationship between self-reported or/and objectively assessed
sleep quality with markers of subclinical CVD. Third,
the effect of acute and chronic sleep deprivation on
subclinical CVD risks. Such association of sleep
parameters with subclinical CVD would provide the
importance of regular sleep habits and would provide
evidence to the stakeholders to consider sleep disturbances as important risk factors for determination of
future risk of CVD events. This systematic review may
also highlight the role of noninvasive cardiovascular
diagnostic procedures in those with sleep disturbances.
Methods
An electronic systematic literature search was
performed using the EMBASE (via EMTREE) and
Medline database (National Library of Medicine,
Bethesda, MD via PubMed) for relevant literature up
to March 2016 (Fig. 1). We used both MeSH and
Emtree terms and relevant free text terms. The following search terms (synonyms and combinations) were
used: “sleep duration” and/or “sleep quality”. These
terms were combined with “sub clinical cardiovascular
disease risks”, “coronary artery calcium (CAC)”,
“carotid intima-media thickness (CIMT)”, “endothelial function and/or microvascular function via flow
mediated dilation (FMD) and/or peripheral arterial
tone (PAT) and/or iontophoresis and/or nailfold capillaroscopy”, and “arterial stiffness via pulse wave
velocity (PWV)”, and/or ankle brachial index (ABI)”.
The search results were manually scanned for relevant articles by three independent reviewers. References of obtained articles were used for additional
articles. The search was limited to original research
studies on human subjects published in English language. We included (1) original research articles, AND
(2) studies that reported subjective and/or objective
sleep duration AND/OR (3) studies that reported
subjective and/or objective sleep quality, AND (4)
studies that reported PSQI good vs PSQI bad sleep
quality and/or insomnia vs. non-insomnia and/or shift
vs. non-shift work and/or arousal index and/or sleep
efficiency (%) and/or sleep Fragmentation index and/
or REM/Non-REM sleep, AND (5) studies that
reported an assessment of Non-Invasive Subclinical
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Fig. 1. Literature Search Strategy
CVD: Cardiovascular disease, CAC: Coronary artery calcium, CIMT: Carotid intimamedia thickness.

CVD assessment tools as Coronary Artery Calcium
(CAC) and/or Carotid Intima Media Thickness
(CIMT) and/or Endothelia function and/or Arterial
stiffness. The aim of this review was to summarize the
evidence of regular daily sleep duration and sleep quality with subclinical CVD, so we excluded any study
that discussed the association of sleep disorders and
clinical cardiovascular and cerebrovascular diseases.
Many research studies have shown that sleep disorders
like obstructive sleep apnea has been previously shown
to be strongly associated with subclinical CVD 18). In
our exclusion criteria, we excluded (1) the letters, editorials (2) the studies on subjects with sleep disorders
[obstructive sleep apnea (OSA), parasomnias, and narcolepsy] (3) the studies that discussed clinical CVDs
210

(angina, myocardial infarction and heart failure) and
cerebrovascular diseases (stroke) (4) the studies that
that have discussed the effect of mental disorders on
sleep duration and sleep quality (5) the studies in
which participants used any kind of sleeping pills.
Thirty-two studies met the inclusion criteria for final
review from an initial search result of 186 articles
(Fig. 1 for search algorithm). The authors stated that
no financial support was given and that no off-label or
investigational use of a drug or device was performed
as part of this research.
Sleep duration typically defines as “the total
amount of sleep obtained, either during the nocturnal
sleep episode or across the 24-hour period” 19). In the
studies discussed in this review, the sleep duration was
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Table 1. Baseline characteristics of studies used in systematic review.
First Author,
Publication
Year,

Country

Study Design

Study Population N
(age;% female)

Sleep
Measurement
(Subjective/Selfreported)

Sleep
Measurement
(Objective)

Non-invasive CVD
measurement

King et al. (33),
2008

United States Cohort

495 (40±4; 59%)

Self-Report
(PSQI)

Actigraphy

CAC (Agatston score)electron beam CT

Matthews et al.
(31), 2011

United States Cross-sectional

195 (60; 50%)

Self-Report
(PSQI)

Actigraphy and
PSG

CAC (Agatston score)electron beam CT

Matthews et al.
(32), 2013

United States Cross-sectional

512 (50±3; 100%)

Self-Report
(PSQI)

NR

CAC (Agatston score)electron beam CT

Lutsey et al (34),
2015

United States Cross-sectional

1465 (68; 54%)

NR

Actigraphy and
PSG

CAC (Agatston score)electron beam CT

Kim et al, 2015
(17)

Korea

Cross-sectional

29203 (41.8±7.3;
18.6%)

Self-Report
(PSQI)

NR

CAC (Agatston score)electron beam CT

Wolff et al. (35),
2008

Germany

Cross-sectional

2383 (45 – 81; 51%)

Self-Report

NR

CIMT (mm)- B-mode
ultrasound

Abe et al. (36),
2011

Japan

Cross-Sectional

2214 (64±10; 52%)

Self-Report
questionnaire

NR

CIMT (mm)- B-mode
ultrasound

Nakazaki et al.
(38), 2012

Japan

Cross-Sectional

86 (74±5; 71%)

Self-Report
(PSQI),

Actigraphy

CIMT (mm)- B-mode
ultrasound

Sands et al. (39),
2012

United States Cohort

617 (37 – 52; 58%)

NR

Actigraphy

CIMT (mm)- B-mode
ultrasound

Nagai et al. (2),
2013

Japan

Cross-Sectional

201 (80±6; 75%)

Self-Report
questionnaire

NR

CIMT (mm)- B-mode
ultrasound

Ma et al. (37),
2013

United States Cross- sectional

257 (42±9; 26%)

Self-Report
(PSQI)

Actigraphy

CIMT (mm)- B-mode
ultrasound

RamosSepulveda et al.
(41), 2010

United States Cross- sectional

1605 (65±8; 60%)

Self-Report
(HRSD)

NR

CIMT (mm)- B-mode
ultrasound

Schwartz et al.
(40) 2102

United States Cross sectional

126 (55; 89%)

NR

Actigraphy

CIMT (mm)- B-mode
ultrasound

Behl et al. (43),
2014

United States Cohort

684 (48±11; 68%)

Self-Report
(PSQI and ESS)

EF-FMD

Cooper et al.
(42), 2014

United States Cross-sectional

100 (36±10; 43%)

Self-Report
(PSQI) and PSG

EF-FMD

Calvin et al. (44),
United States Cross-sectional
2014

16 (18 to 40; 37.5%)

Takase et al,
2004 (45)

Japan

Cross-sectional

Wehrens et al,
2012 (46)

United
Kingdom

Schmidt et al,
2013 (47)

Germany

NR

PSG

EF- FMD

30 (21.7±1.1; 0%)

Self-Report

NR

EF-FMD

Cross-sectional

25 (25 – 45; 0%)

Self-report
questionnaire

NR

EF-FMD

Cross-sectional

75 (20 – 54; 61.3%)

NR

Actigraphy

EF-FMD
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(Cont Table 1)

Study Design

Study Population N
(age;% female)

Sleep
Measurement
(Subjective/Selfreported)

Sleep
Measurement
(Objective)

Strand et al. (48),
Norway
2012

Cross-sectional

4739 (50±13; 45.2%)

Self-report
questionnaire

NR

EF-FMD

Suessenbacher et
al. (49), 2011

Austria

Cross-sectional

48 (43±5; 0%)

Self-report
questionnaire

NR

EF- PAT index

Dettoni et al.
(50), 2012

Brazil

Cross-sectional

13 (31±2; 0%)

NR

Actigraphy

EF (dorsal hand vein
technique)

Sauvet et al. (51),
France
2009

Cross-sectional

12 (29±3; 0%)

Self-report

NR

EF (Iontophoresis of
Acetylcholine & Nanitroprusside)

Bonsen et al.
(52), 2015

Netherlands

Cross-sectional

259 (42; 55%)

Self-report
(SWEL)

NR

EF- Nailfold
capillaroscopy

Weil et al. (53),
2010

United States Cross-sectional

80 (56.6±1.2; 39%)

Self-Report

NR

EF- Endothelin (ET)-1
levels

Weil et al. (54) ,
2011

United States Cross-sectional

37 (58±1.5; 41%)

Self-Report

NR

EF- Endothelial
progenitor cells (EPCs)
functions

Yoshioka et al.
(55), 2011

Japan

Cross-sectional

4268 (48±7; 20%)

Self-Report

NR

AS-baPWV

Sunbul et al.
(56), 2014

Turkey

Cross-sectional

42 (30±5; 57%)

Self-report
questionnaire

NR

AS-baPWV

Tsai et al. (57),
2014

Taiwan

Cross-sectional

3, 508 (age 20 – 87,
40%)

Self-Report

NR

AS-baPWV

Osonoi et al,
2015 (68)

Japan

Cross-sectional

724 (57.8±8.6;
37.1%)

Self-Report
(PSQI)

NR

AS-baPWV

Yamaki et al.
2015,

Japan

Cross-sectional

101 (70.0±10; 46.5%)

Self-Report
(PSQI)

NR

AS-ABI

First Author,
Publication
Year,

Country

Non-invasive CVD
measurement

Abbreviation: NR: Not – reported; SWEL: Sleep Wake Experience List questionnaire

measured either via subjective methods, including selfreported questionnaires and/or Pittsburg Sleep Quality Index (PSQI) or via objective measures, which
include actigraphy and/or polysomnography or by
both subjective and objective methods 20, 21). The subjective sleep quality is defined as “one’s perception that
they fall asleep easily, get sufficient duration so as to
wake up feeling rested, and can make it through their
day without experiencing excessive daytime sleepiness” 22). Using actigraphy to objectively measure sleep
quality, the objective sleep quality is defined by sufficient duration ( ＞ 7 hrs), high efficiency ( ＞ 85%), and
low fragmentation ( ＜ 25) 23). Using polysomnography
(PSG) the sleep architecture is added to the equation,
212

whereby the objective sleep quality is defined not only
by sufficient duration, high efficiency, and low fragmentation, but also by proper staging of sleep (i.e.,
cycling through non-REM (stages 1 – 4) and REM) 23).
In this review, the sleep quality was measured via subjective methods, including Pittsburg Sleep Quality
Index (PSQI) and/or self-reporting of insomnia vs
non-insomnia, shift vs non-shift work, arousal index,
or via objective measures, which include actigraphy
and/or polysomnography or by both subjective and
objective methods 20, 21). The Pittsburgh Sleep Quality
Index (PSQI) is an effective tool used to measure the
quality and patterns of sleep in adults. It differentiates
“poor” from “good” sleep quality by measuring seven
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Table 2a. Association of Subjective/ Self-reported and Objective Sleep Duration with Coronary Artery Calcium (CAC)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Subclinical CVD
assessment tools.

Results

Comments

Subjective/ Self-reported Sleep Duration
CAC

Logistic regression of incident CAC [OR (95% CI):
Self-reported sleep per hour (Adj a): 0.87 (0.67 – 1.13),
p = 0.30

Self-Report
(PSQI),

CAC

Self-reported Sleep duration (hr) among CAC groups:
CAC = 0: 6.41 (1.25)
CAC = 1 – 99: 6.51 (1.18)
CAC = 100＋: 6.48 (1.19), p = 0.88

Self-Report
(PSQI)

CAC

No significant association between longer self-reported
sleep duration and increased CAC in linear (p = 0.19) or
logit models (p = 0.06)

CAC

Sleep duration vs. CAC Score (Adj b): OR (95% CI)
≤ 5 h: 1.50 (1.17 – 1.93); p: 0.002
6 h: 1.34 (1.10 – 1.63); p: 0.002
7 h: 1.00 (Reference)
8 h: 1.37 (0.99 – 1.89); p: ≥ 0.05
≥ 9 h: 1.72 (0.90 – 3.28); p: 0.002

CAC

Logistic regression of incident CAC [OR (95% CI):
Actigraph measured sleep per hour (Adj c): 0.66 (0.48 –
0.92), p = 0.01

King et al. (33),
2008

Self-Report
(PSQI)

Matthews et al.
(31), 2011

Matthews et al.
(32), 2013

Kim et al, 2015
(17)

Self-Report
(PSQI)

Women only
sample

The association
between sleep duration and CAC is
“U-shaped”.

Objective Sleep Duration
King et al. (33),
2008

Actigraphy

Objective sleep duration (hr) among CAC groups:

Matthews et al.
(31), 2011

Actigraphy,
Polysomnography

CAC

Actigraphy:

PSG

CAC = 0

5.78 (0.98)

6.11 (0.91)

CAC = 1-99

5.80 (0.82)

6.16 (1.00)

CAC = 100＋

5.92 (0.79)

5.90 (1.04)

p = 0.64

p = 0.89

P value
Lutsey et al (34),
2015

Polysomnography
and actigraphy

CAC

Sleep duration (h) vs CAC ≥ 400: PR (95% CI):
≤ 6.65h: 0.75 (0.55 – 1.03), p = 0.08
6.65 – 7.4 h: Ref
≥ 7.40h: 0.84 (0.56 – 1.26), p = 0.40

Sleep duration both
by Actigraphy and
PSG was not significant

Fully adjusted
model is not related
to high prevalence
of CAC.

a Adjusted for race, sex, age, smoking, education, and apnea risk
b Adjusted for age, sex, study center, year of visit, education, marital

status, depression, smoking status, alcohol consumption, physical activity, body
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
c Adjusted for race, sex, age, smoking, education, apnea risk, BMI, HDL, LDL, BP, DM

sleep components that include subjective sleep quality,
sleep latency, sleep duration, habitual sleep efficiency,
sleep disturbances, use of sleeping medications, and
daytime dysfunction over the last month 24). Sleep
fragmentation is defined as “an index of restlessness
during the sleep period expressed as a percentage”. It
is calculated as movement index, a fragmentation
index, and total sleep fragmentation Index. The higher

the sleep fragmentation index, the more sleep is disrupted 25).
Among subclinical cardiovascular disease (CVD)
measures, the coronary artery calcium (CAC) was
measured by either electron beam computed tomography (EBCT) or multidetector computed tomographic
(MDCT) scanner. Increased calcium deposition in
coronary arteries is related to the presence of athero213
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Table 2b. Association of Subjective/ Self-reported and Objective Sleep Quality with Coronary Artery Calcium (CAC)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive Subclinical CVD
assessment tools.

Results

Comments

Subjective/ Self-reported Sleep Quality

CAC

Logistic regression of incident CAC: (OR; 95%CI):
PSQI Score (per SD = 2.9 points) (Adj d): 1.21 (0.88 –
1.65), p = 0.24
Epworth Score (per SD = 4.0 points) (Adj d): 1.26 (0.96,
1.66), p = 0.10

Self-Report
(PSQI)

CAC

Self-reported sleep quality or efficiency did not differ by
CAC groups (p ＞ 0.15)

Self-Report
(PSQI)

CAC

Poor sleep quality was not associated with odds of being
in a higher coronary artery calcification (CAC) group.

Women only

CAC

CAC Score by sleep quality: Adj b OR (95% CI): Good
vs. Poor sleep quality:
Men: 1.00 (Reference) vs. 1.10 (0.86 – 1.42)
Women: 1.00 (Reference) vs. 2.46 (1.30 – 4.65); p ≤ 0.05

Poor subjective sleep
quality was associated
with CAC in women
only in both crude and
adjusted model.

King et al. (33),
2008

Self-Report
(PSQI)

Matthews et al.
(31), 2011
Matthews et al.
(32), 2013

Kim et al, 2015
(17)

Self-Report
(PSQI)

Apnea/Hypopnea
Index was associated
with increased CAC
scores (p = 0.04).

Objective Sleep Quality
King et al. (33),
2008

Actigraphy

CAC

Logistic regression of incident CAC: (OR; 95%CI)
Fragmentation Index (per SD = 7.7 points) d: 1.07 (0.80,
1.42), p = 0.66

Matthews et al.
(31), 2011

Actigraphy,
Polysomnography

CAC

Sleep quality or efficiency measures did not differ by
CAC groups (CAC = 0 vs CAC ＞ 0); p ＞ 0.05

CAC

Sleep quality vs CAC ≥ 400: PR (95% CI)
Arousal index — 1.14 (1.02 to 1.27); p = 0.02
Arousal index — REM: 1.15 (1.02 to 1.29); p = 0.02
Arousal index — NREM: 1.14 (1.02 to 1.28); p = 0.03
Average sleep efficiency% — 1.00 (0.89 to 1.13); p = 0.97
Average sleep WASO — 1.03 (0.91 to 1.17); p = 0.62

Lutsey et al
(34), 2015

Polysomnography
and actigraphy

d
Adjusted
b

for race, sex, age, smoking, education, and apnea risk.
Adjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.

sclerotic process and increased plaque burden 12). The
carotid intima-media thickness (CIMT) was measured
using high-resolution B-mode ultrasonography on
carotid arteries and increased intima media thickness
in carotid artery is related to carotid atherosclerosis
and future increased risk of CVD 13). The endothelial
function and/or microvascular function was measured
by flow mediated dilation (FMD) and/or peripheral
arterial tone (PAT) and/or iontophoresis and/or nailfold capillaroscopy. The FMD is based on an ultrasound test that measures the changes in the arterial
diameter based on their blood flow such as the bra214

chial, radial or femoral arteries. The decrease in the
flow mediated dilatation is closely related to endothelial cells dysfunction that leads to increased risk of vessels wall injury causing both the early and late mechanisms of atherosclerosis that include increased leukocyte adherence, platelet activation, and vascular smooth
muscle proliferation and decreased production of nitric
oxide 14). The PAT is calculated by EndoPAT device
(Itamar Medical, Israel) that involves measuring the
pulse amplitude in the fingertip at rest and following
the induction of reactive hyperemia. The EndoPAT
device consists of a fingertip plethysmograph capable
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Table 3a. Association of Subjective/ Self-reported and Objective Sleep Duration with Carotid Intima-Media Thickness (CIMT)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Subclinical CVD
assessment tools

Results

Comments

CIMT

Mean difference (mm) in CIMT across hours of sleep: Adj e
5h: 0.038 (0.002, 0.074); p ＜ 0.0
6h: 0.007 (−0.012, 0.027); ns)
7h: 0.001 (−0.015, 0.018); ns)
8h: ref group
9h: 0.022 (0.000, 0.045); ns
10h: 0.043 (0.015, 0.070); p ＜ 0.01
＞ 11h: 0.065 (0.017, 0.113); p ＜ 0.01

The association of sleep
duration with mean
CIMT was J-shaped. The
sleep duration group of
7hrs exhibited lowest
CIMT, SBP and HbA1c.

CIMT

Odds ratio for presence of IMT ≥ 1.2 mm: Adj f
≤ 5h: 1.059 (0.764 – 1.467), p = ≥ 0.05
6h: ref group
≥ 7h: 1.263 (1.031 – 1.546), p = 0.024

The use of hypnotics like
benzodiazepines diminished the association
between sleep duration
and increased CIMT.

CIMT

Mean CIMT (mm): ＜ 5h sleep vs. ＞ 7h sleep: (1.3±0.5
vs. 0.9±0.3); p = 0.009
Association of sleep duration by PSQI with CIMT g:
β= 0.22, p = 0.05

Subjective/Self-reported Sleep Duration

Wolff et al. (35),
2008

Self-Report
questionnaire

Abe et al. (36),
2011

Self-Report
questionnaire

Nakazaki et al.
(38), 2012

Self-Report
(PSQI)

Nagai et al. (2),
2013

Self-Report
questionnaire

Elderly population.

CIMT (mm) among sleep groups:

Ma et al. (37),
2013

Self-Report
(PSQI)

CIMT

CIMT

＜ 6 hr: 1.03±0.29
≤ 6 – 9 hr: 1.01±0.29
≥ 9 hr: 1.09±0.35, (p = 0.26)

Self-report sleep duration and Mean CIMT (mm):
3.0 – 4.9h: 0.657±0.024
5.0 – 5.9h: 0.615±0.012
6.0 – 6.9h: 0.624±0.011
7.0 – 7.9h (Reference): 0.617±0.012
8.0 – 10: 0.607±0.020, (p for all = 0.830)

of sensing volume changes in the digit with each arterial pulsation. The volume changes in the fingertip are
documented digitally as pulse amplitude that can be
tracked over time. The expected response is a post
occlusion increase of the PAT signal amplitude and
the PAT score is provided automatically by the system’s software and is basically the ratio between the
post- to pre-occlusion average signal size, corrected for
systemic changes and baseline level 26). Iontophoresis
of acetylcholine (ACh) and sodium nitroprusside
(SNP) is a tool used to determine microvascular endothelial function. Two laser-Doppler probes specifically
designed with an embedded sponge for skin iontophoresis of agonists are fixed 5 cm apart to the skin with
an adhesive patch to measure the endothelium-dependent and endothelium-independent vasodilatation to
determine the endothelial function 27). The nailfold
capillary video microscopy of the dorsal skin of the

Elderly population.

Police officers.

third finger is used to determine the endothelial function. The measurements are conducted after at least
30 min of rest and with a minimum hand temperature
of 28 ℃. The microvascular measurements include the
duplicate measurements of capillary density at the
base of the interphalanx at rest and after 4 min of arterial occlusion 28). The arterial stiffness was measured
via pulse wave velocity (PWV), and/or ankle brachial
index (ABI). The PWV is the time the arterial pressure wave takes to travel a distance between two arterial sites and is measured distance (cm)/time (seconds).
Higher value of PWV is directly correlated to the arterial stiffness and when measured over the aorta, it represents an independent risk factor for increased cardiovascular disease 15). There are different methods to
measure the PWV that include brachial artery PWV
(baPWV), carotid-femoral PWV (cfPWV), heart-femoral PWV (hfPWV) and femoral-ankle PWV
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(Cont Table 3a)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Subclinical CVD
assessment tools

Results

Comments

Objective Sleep Duration
Nakazaki et al.
(38), 2012

Sands et al.
(39), 2012

Ma et al. (37),
2013

Schwartz et al.
(40) 2102

Actigraphy

Actigraphy

Actigraphy

Actigraphy

CIMT

Association of total sleep time by Actigraphy with
CIMT g: β=−0.32, p = 0.005
Sleep efficiency (%): Insomnia group vs. non-insomnia
group (78.6±11.3 vs. 89.3±7.1); p =＜ 0.0001

Elderly population.

CIMT

Linear regression for sleep duration (h) on CIMT (mm)
Adj h: OR (95% CI)
Male: −0.026 (−0.047, −0.005); p = 0.02
Female: −0.001 (−0.020, 0.022); p = 0.91

Model significant in men
only.

CIMT

Actigraphy measured sleep duration and mean CIMT
mm (SE) (Adj i):
1.7 – 4.9h: 0.633±0.012
5.0 – 5.9h: 0.617±0.010
6.0 – 6.9h: 0.623±0.012
7.0 – 7.9h (Reference): 0.590±0.019
8.0 – 10.7: 0.625±0.027 (p for all = 0.692)

CIMT

Sleep duration (h) vs. CIMT (mm): β (95% CI) j
Nighttime sleep duration: −0.01 (−0.03, 0.01); p ≥ 0.05
Daytime sleep duration: −0.04 (−0.07, −0.01); p ≤ 0.05

Police officers. .

Study was done on elderly
Alzheimer Caregivers

e

Adjusted for lifestyle variables include smoking status (number of cigarettes per day), alcohol consumption, physical activity, and shift work;
socioeconomic factors include monthly family income, marital status, primary education, vocational status; and biological risk factors include BMI,
lipid profile (total cholesterol/HDL cholesterol ratio), diabetes, previous myocardial infarction and hypertension.
f Adjusted for age, sex, LDL-cholesterol, HDL-cholesterol, triglyceride, fasting plasma glucose, HbA1c, fasting insulin, BMI, alcohol intake (never,
monthly, weekly, daily), and current smoking
g Adjusted for age, gender, BMI, SBP, DBP, PSQI, AHI, lowest SpO2, sleep efficiency, total sleep time, hypertension, hyperlipidemia, diabetes, sleep
apnea syndrome and insomnia.
h Adjusted for age, race/ethnicity, smoking, education, depression, BMI, systolic blood pressure, high- density lipoprotein cholesterol, low- density
lipoprotein cholesterol, and diabetes
i Adjusted for age, gender, race/ethnicity, abdominal height, systolic blood pressure, anti-hypertensivemedications, glucose, low-density lipoprotein,
high-density lipoprotein, lipid lowering medications, sleep quality (Pittsburgh Sleep Quality Index global score after removing sleep duration component), perceived stress score, depressive symptoms score, physical activity index, smoking status, shiftwork, and having a second job.
j
Adjusted for age and gender, education, BMI, physical activity, smoking, hypertension, dyslipidemia, diabetes, history of CVD, Role Overload and
depression (CESD-10) scores

(faPWV) and these reflect properties of central,
peripheral or mixed properties of both central and
peripheral arterial stiffness. All studies used in this
review discussed the relationship of sleep parameters
with baPWV which is considered as an important
parameter of both central and peripheral arterial stiffness 29). ABI is a measure reflective of systemic atherosclerosis and predict the stiffness in the vessels. The
ABI is the ratio of the systolic blood pressure at the
ankle to the average systolic blood pressure at the right
arm. The lower the value of ABI below 1.0 correlates
with the severity of arterial stiffness 30).
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Results
Thirty-two studies met the final selection criteria
and discussed the relationship of subjective (self-report)
and objective (actigraphy and/or polysomnography)
sleep duration as well as subjective and objective sleep
quality with non-invasive markers of subclinical CVD.
Sleep duration and sleep quality are two distinct
parameters of sleep, and these are discussed separately
along with each non-invasive marker of subclinical
CVD in respective tables. Five studies evaluated association of sleep parameters with coronary artery calcium (CAC) 17, 31-34), eight evaluated association with
carotid intima-media thickness (CIMT) 2, 35-41), thirteen evaluated association with endothelial func-
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Table 3b. Association of Subjective/ Self-reported and Objective Sleep Quality with Carotid Intima-Media Thickness (CIMT)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Sub-clinical CVD
assessment tools.

Results

Comments

Subjective/Self-reported Sleep Quality
Abe et al. (36),
2011

Self-Report
questionnaire

CIMT

Sleep quality was not significantly associated with CIMT
(p = ≥ 0.05)

Japanese population.
Elderly population
only.

Elderly patients.

Nakazaki et al.
(38), 2012

Self-Report
(PSQI)

CIMT

Association of sleep quality by PSQI with CIMT k: β= 0.22,
p = 0.05
Mean IMT (mm): Insomnia group vs. non-insomnia group
(1.3±0.5 vs. 1.1±0.4); p = 0.03

Nagai et al. (2),
2013

Self-Report
questionnaire

CIMT

Mean IMT (mm): Insomnia group vs. non-insomnia group
(1.16±0.37 vs. 1.04±0.30); p ＜ 0.01

Ma et al. (37),
2013

Self-Report
(PSQI)

CIMT

PSQI sleep quality score& CIMT (mm):
Pearson correlation coefficient (r) =−0.0762; p = 0.235

CIMT

Association of insomnia with CIMT (mm)Adj l: OR (95% CI)
1.08 (0.70 – 1.66); β=−0.0012, p = 0.829

Multi-ethnic population

CIMT

Sleep quality vs. CIMT (mm): β (95% CI) j
Nighttime WASO: 0.04 (0.001, 0.08), p ≤ 0.05

Study was done on
elderly Alzheimer
Caregivers

Ramos-Sepulveda
et al (41), 2010

Self-Report
(HRSD)

Police officers.

Objective Sleep Quality
Schwartz et al.
(40) 2102

Actigraphy

k Adjusted

for age, gender, BMI, SBP, DBP, PSQI, AHI, lowest SpO2, sleep efficiency, total sleep time, hypertension, hyperlipidemia, diabetes, sleep
apnea syndrome and insomnia.
l
Adjusted for age sex, race LDL, HDL BMI hypertension, diabetes, current smoker and any cardiac disease.
j Adjusted for age and gender, education, BMI, physical activity, smoking, hypertension, dyslipidemia, diabetes, history of CVD, Role Overload and
depression (CESD-10) scores.

tion 42-54), and six studies assessed relationship with
arterial stiffness 17, 55-58). Kim et al. 2015 studied both
the subjective sleep duration and subjective sleep quality with both CAC as well as PWV in same paper so
the results of CAC and PWV outcomes were stated
separately in the relevant tables 17). Table 1 shows the
baseline characteristics of all the studies used in this
review.
Association of Subjective and Objective Sleep
Parameters with Coronary Artery Calcium (CAC)
Table 2a shows the association of subjective and
objective sleep duration with CAC. Kim et al. showed
that association of subjective sleep duration with CAC
is “U” shaped with stronger association of short subjective sleep duration with increased CAC. King et al.
showed that objective longer sleep duration is better
predictor of CAC as compared to objective shorter
sleep duration with 0.66 times increase in CAC with
each hour increase in sleep duration. All other studies
did not show any significant association of sleep duration with CAC.
The association of sleep quality with CAC is less

robust with only one study among the total of three
showed that poor sleep quality is associated with
increased CAC among women only. Objective sleep
quality only in the form of arousal index was directly
associated with increased CAC as, higher the arousal
index, higher the risk of being in a CAC group of
CAC ≥ 400 Agatston units (Table 2b)
Association of Subjective and Objective Sleep
Parameters with Carotid Intima Media Thickness
(CIMT)
Table 3a showed that subjective and objective
sleep duration were associated with CIMT with stronger evidence present for shorter sleep duration with
increased CIMT as compared with reference sleep
hours (6 – 8 hours). The population used in these
studies was heterogeneous with mostly elderly and
police officers. Among all studies assessing the CIMT,
the sleep duration group of average 7 hours exhibited
lowest systolic blood pressure and Hemoglobin A1c.
Table 3b showed that most of the studies discussed the relationship of subjective sleep duration
with CIMT. Only one study discussed association of
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Table 4a. Association of Subjective/ Self-reported and Objective Sleep Duration with Endothelial Function (EF)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Subclinical CVD
assessment tools.

Results

Comments

Subjective/Self-reported Sleep Duration
Behl et al. (43),
2014

Bonsen et al.
(52), 2015

Weil et al. (53),
2010

Weil et al. (54),
2011

Self-Report
(PSQI)

EF (FMD)

Total PSQI score was unrelated to brachial artery
FMD; p = ≥ 0.05

EF (nailfold
Capillaroscopy)

Sleep duration & endothelial function: regression
coefficient 95% CI
Men: β=−0.79, 95% CI (−7.20 to 5.63), p = 0.81
Women: β=−11.17, 95% CI (−21.80 to −0.55);
p = 0.04

Self-Report
questionnaire

EF [Endothelin
(ET)-1 levels]

Sleep duration and endothelial function as ET-1mediated vasoconstrictor tone: (Correlation) r =
−0.32; p ＜ 0.01

Increased ET-1 vasoconstrictor activity positively
correlated with CVD risks.

Self-Report
questionnaire

EF [endothelial
progenitor cells
(EPCs) functions]

There were no significant correlations between
sleep duration and any endothelial progenitor
cells (EPCs) measure.

Circulating endothelial
progenitor cells (EPCs) are
vital to endogenous vascular repair processes and
cardiovascular health.

EF (FMD)

Total sleep time (TST) was not associated with
FMD: (Correlation) r = 0.03; p = ≥ 0.05

Self-Report
questionnaire

Significant only in
women

Objective Sleep Duration
Cooper et al.
(42), 2014

Polysomnography

the objective sleep quality with CIMT and it was significant (p ≤ 0.05). Among these studies insomnia was
strongly associated with CIMT as compared to noninsomnia. PSQI as a parameter of sleep quality was
discussed only in two studies and was significant only
in one study (β= 0.22, p = 0.05).
Association of Subjective and Objective Sleep
Parameters with Endothelial Functions
Table 4a discussed the subjective and objective
sleep duration with endothelial functions. Among
total of five studies, only one study discussed the
objective sleep duration and endothelial functions and
it was not significant. Among the other four studies,
only two studies showed the significant association of
subjective sleep duration with endothelial dysfunctions.
Table 4b discussed the subjective and objective
sleep quality with endothelial functions. Most of the
studies showed a significant association of low sleep
quality with reduced endothelial functions. The low
sleep quality was expressed variably in these studies by
PSQI quality scores, acute sleep deprivation, difficulties initiating sleep or maintaining sleep, REM sleep,
REM latency, noise level during sleep, chronic stress
vs no stress, shift vs. non-shift workers.
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Association of Subjective and Objective Sleep
Parameters with Arterial Stiffness
Table 5a discussed the association of subjective
sleep duration with arterial stiffness. All studies
showed that subjective long sleep duration was associated with increased arterial stiffness; however, only
one study showed a relationship between subjective
short sleep duration and arterial stiffness and other
studies failed to demonstrate such association.
In Table 5b, all studies that discussed the subjective association of sleep quality with arterial stiffness,
showed a strong positive association of bad sleep quality with arterial stiffness in terms of increased brachial
artery pulse wave velocity (baPWV) and decreased
ankle brachial index (ABI). There was no study in this
review that reported the association of objective sleep
quality with arterial stiffness.
Discussion
This systematic review investigated the association of subjectively and/or objectively measured sleep
duration as well as sleep quality with non-invasive
markers of sub-clinical cardiovascular disease (CVD).
According to this review, subjective short sleep duration was associated with CAC and CIMT, but variably

Sleep Duration and Quality with Subclinical CVD

Table 4b. Association of Subjective/ Self-reported and Objective Sleep Quality with Endothelial Function (EF)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Sub-clinical CVD
assessment tools.

Results

EF (FMD)

Low PSQI quality component was associated with
lower FMD; p = 0.038
Higher ESS scores were associated with lower
FMD; p = 0.026

Comments

Subjective/ Self-reported Sleep Quality
Behl et al. (43),
2014 Cohort
study

Self-Report
(PSQI)

Cooper et al.
(42), 2014
Cross-sectional

Self-Report
(PSQI)

EF (FMD)

Total PSQI Scores and FMD%: β=−0.22;
p = 0.024
% REM sleep and FMD%: β= 0.25; p = 0.022
REM latency and FMD%: β=−0.2; p = 0.036

Takase et al,
2004 (45)

Self-report

EF (FMD)

FMD (%): Controls vs. Chronic stress:
7.4±3.0 vs 3.7±2.3; p ＜ 0.05

Only male sample

Wehrens et al,
2012 (46)

Self-report
questionnaire

EF (FMD)

There were no significant effects of day, time,
group, or interactions on%FMD among both
shift and non-shift workers.

Only male sample

Strand et al.
(48) 2102
Cross-sectional

Self-report
questionnaire

EF (FMD)

There was no evidence for an association of
having difficulties initiating sleep or maintaining
sleep with FMD in both genders.

Suessenbacher
et al. (49), 2011

Self-report
questionnaire

EF (PAT index)

Sauvet et al. (51),
2009

Self-Report

EF (Iontophoresis
of Ach & Nanitroprusside)

The endothelium-dependent and – independent
cutaneous vascular conductance were significantly
decreased after 29 h of TSD (P ≤ 0.05).

Bonsen et al.
(52), 2015

Self-report
(SWEL)

EF (Nailfold
capillaroscopy)

Sleep quality& endothelial function: regression
coefficient 95% CI
Men: β −3.81, 95% CI (−9.45, 1.83); p = 0.18
Women: β 2.11, 95% CI (−3.14, 7.36); p = 0.43

PAT index: shift vs non- shift workers:
1.73±0.4 vs 1.94±0.5; p = 0.03

associated with endothelial dysfunction (ED) and
arterial stiffness, however subjective long sleep duration was associated with CAC, CIMT and arterial
stiffness, but variably associated with ED. Objective
short sleep duration was positively associated with
CIMT, variably with CAC but not associated with
ED. Objective long sleep duration was variably associated with CAC and CIMT but not associated with
ED. Poor subjective sleep quality was significantly
associated with ED & arterial stiffness but variably
associated with CAC& CIMT. Poor objective sleep
quality was significantly associated with CIMT, and
ED but variably associated with CAC (Table 6)
There is a growing body of literature linking
sleep duration with CVD outcomes. Sabanayagham et
al. revealed a higher odds of myocardial infarction and
stroke in subjects that slept ≤ 5 h and ≥ 9h 59). In 2011,
Cappuccio et al. performed a systematic review show-

Only male sample
40 hours of total sleep
deprivation.

ing that both short and long sleep durations were
associated with a greater relative risk of coronary heart
disease and stroke 60). Sleep quality as assessed by
insomnia and sleep deprivation have also been linked
with adverse CVD outcomes. Westerlund et al.
revealed that insomnia itself was not related to CVD
risk, but when considered together with short sleep
duration, there was a higher risk of overall cardiovascular events 3). The exact mechanism by which compromised sleep quality lead to CVD is not clear, but
possible explanations include changes in hormones
and inflammatory markers, lipid levels, glucose tolerance/metabolism, sympathetic nervous system and
subclinical atherosclerosis 61). Cappuccio et al. performed another systematic review and meta-analysis in
2010 of 10 cohort studies showing that sleep ≤ 5 – 6 h
and ＞ 8 – 9h were associated with higher relative risk
of developing Type 2 DM 62). Gangwisch et al. showed
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(Cont Table 4b)
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Sub-clinical CVD
assessment tools.

Results

Comments

Objective Sleep Quality
Cooper et al.
(42), 2014
Cross-sectional

Calvin et al.
(44), 2014
Cross-sectional

Schmidt et al,
2013 (47)

Polysomnography

Polysomnography
(PSG)

Actigraphy

Dettoni et al. (50),
Wrist actigraphy
2012

EF (FMD)

% REM sleep and FMD%: β= 0.25; p = 0.022
REM latency and FMD%: β=−0.2; p = 0.036

EF (FMD)

FMD%: Acclimation phase vs. Experimental phase
Sleep restriction group: 8.6±4.6% vs 5.2±3.4%;
p = 0.01
Control group: 5.0±3.0% vs 6.73±2.9%; p = 0.10
Group differences: −4.40%. 95% CI (−7.00,
−1.81); p = 0.003

Smaller sample

EF (FMD)

FMD% among groups:
Control: 10.4＋3.8%;
Noise30 dB: 9.7＋4.1%;
Noise60 dB: 9.5＋4.3%; p = 0.052
A monotone dose-dependent effect of noise level
on FMD was significant (p = 0.020)

There was a priming
effect of noise, i.e. the
blunting in FMD was
particularly evident when
subjects were exposed
first to 30 and then to 60
noise events (p = 0.006).

Endothelial dependent venodilatation in sleep
groups:
Control sleep ( ＞ 7h): 100±22%
Partial sleep deprivation (＜ 5 h): 41±20%); p ＜
0.05

5 nights of partial sleep
deprivation was sufficient
to cause significant
venous endothelial
dysfunction.

EF (dorsal hand
vein technique)

that ≤ 5 hours of sleep significantly increased the risk
of hypertension 63). Dettoni et al. showed that five
nights of partial sleep deprivation can significantly
cause a trigger in the sympathetic activity and venous
endothelial dysfunction and this evidence is in alignment with the association between short sleep and
increased cardiovascular risk in other epidemiological
studies 50).
Many animal studies have also found sleep deprivation causes an increase in endothelin levels. Endothelin is a potent vasoconstrictor that has been implicated in the pathogenesis of hypertension 64). MeierEwert et al. revealed that both total (88 hrs of no
sleep) and short-term partial sleep (4.2 hrs of sleep)
deprivation resulted in elevated high-sensitivity CRP
concentrations, compared to those who slept 8.2
hours 65). Sauvet et al. demonstrated that total sleep
deprivation in rats induces a reduction in endothelialdependent vasodilation independent of blood pressure
and sympathetic activity 64). Carreras et al. showed in
mice that long-term sleep fragmentation lead to vascular endothelial dysfunction, mild increase in blood
pressure, vascular elastic fiber disruption and disorganization, and increased recruitment of inflammatory
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cells 66). According to a review by Elliott et al. sleep
deprivation can cause death sooner than food deprivation in both Drosophila and rats, further favoring
importance of regular sleep habits 67).
Our review provided mixed results in terms of
subjective and/or objective short and/or long sleep
duration and sleep quality with sub-clinical CVD,
with a greater percentage of studies showing a relationship with sub-clinical CVD. However, only some
studies in this review failed to demonstrate such an
association 31, 32, 37, 43) and one possible reason for such
results could be due to the use of subjective/self-report
versus objectively measured sleep parameters to assess
the association with subclinical CVD causing biased
results. Lauderdale et al. found a correlation between
self-reported and objectively measured sleep duration
of 0.45, which is generally considered as a moderate
correlation. In current review, while one study reports
a “J-shaped” association 35), the other two study reports
a “U- shaped” association 17, 37) between sleep duration
and sub-clinical CVD outcomes. Some studies report a
positive association of sleep duration with sub-clinical
CVD only with short sleep duration; some only with
long sleep duration; some studies show a positive asso-
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Table 5a. Association of Subjective/ Self-reported and Objective Sleep Duration with Arterial Stiffness.
First Author,
Publication Year,
Study Type

Sleep
Measurement

Non-Invasive
Subclinical CVD
assessment tools.

Results

Comments

Subjective/Self-reported Sleep Duration

Yoshioka et al.
(55), 2011

Tsai et al. (57),
2014

Kim et al. (17),
2015

Self-Report
questionnaire

Self-Report
questionnaire

Self-Report
(PSQI)

baPWV

Association of sleep duration and mean baPWV:
PRC (95%CI) Adj m:
≤ 5h, 6h, 8 h, p = ≥ 0.05
≥ 9hr: 44.69 (17.69-71.69); p ＜ 0.01

baPWV

Relationship of sleep duration with arterial
stiffness: Adj n
Males: Short Sleep: 0.98 (0.72 – 1.35); p = 0.920
Long sleep: 1.75 (1.04 – 2.94); p = 0.034
Females: Short Sleep: 0.86 (0.56 – 1.31); p = 0.476
Long Sleep: 1.02 (0.48 – 2.15); p = 0.963

baPWV

Sleep duration (h) vs PWV (cm/s) (Adj b): OR
(95% CI)
＜ 5h: 6.7 (0.75 – 12.6)
6h: 2.9 (−1.7 to 7.4)
7h: Reference (0.0)
8h: 10.5 (4.5 – 16.5)
9h: 9.6 (−0.7 to 19.8); p = 0.019

In gender stratified analyses, ≥ 9h sleep duration
was associated with
increased baPWV in males
only (p ＜ 0.01).

The association between
sleep duration and baPWV
was U-shaped

Objective Sleep Duration
Not even a single study have described the association of objective sleep duration with Arterial Stiffness.
m
Adjusted for age, sex, SBP, hypertension, HR, biological risk factors (BMI, TC, log TG, HDL-C, and FBS), lifestyle factors (education, exercise,
smoking, and alcohol consumption), and occupational factors (occupation, working hours, shift work, days off, and job strain)
n Adjusted for age, BMI, eGFR, Hypertension, DM, TC/HDL-C, sleep duration, smoking, alcohol drinking, regular exercise, and snoring ≥ 3/week
b
Adjusted for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.

ciation with both short and long duration 33, 38, 39, 57)
but almost all studies favor the duration of the reference sleep (average 6 – 8 hours of regular daily sleep).
To our surprise, some studies have even shown long
sleep hours is related to decrease in CAC 33), decrease
in CIMT 38-40), decrease in PWV 56) and one study by
Yoshioka et al. 55) even showed that sleep duration of
≤ 6 hours was associated with a significant decrease in
PWV and thus produced a great source of heterogeneity in the review. Although most of the studies in the
current review demonstrate that sleep parameters are
associated with early sub-clinical CVD, there is, as yet,
no consensus on the biological pathways linking these
processes. It is entirely possible, given the complexity
of factors responsible for sleep habits that sleep disturbances may be an epiphenomenon of subclinical and
clinical CVD rather than the proximate cause 1). The
population used in these studies is highly heterogeneous based on age and gender differences, and thus
no consensus can be made about the particular nature

of subclinical CVD burden due to changes in the
sleep parameters in specific age groups and gender.
Our systematic review findings need to be considered in light of the following limitations. The metaanalysis for this review is not applicable because the
studies included in our review are highly heterogeneous in population, outcome reporting and sleep
duration and quality assessment groups, precluding a
quantitative or meta-analytical synthesis of evidence.
Some studies reported only subjective measures of
sleep duration and sleep quality, some only objective
measures, and some both. Not all studies used similar/
standardized subjective and objectives measures of
sleep duration and quality. Some studies used simple
questionnaire to measure sleep duration and quality,
some used Pittsburgh Sleep Quality Index (PSQI),
some used actigraphy and some used polysomnography creating further heterogeneity in assessment of
predictor variable. Furthermore, the reference/control
sleep duration used in these studies was not a stan221
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Table 5b. Association of Subjective/ Self-reported and Objective Sleep Quality with Arterial Stiffness.
First Author,
Publication Year

Sleep
Measurement

Non-Invasive Subclinical CVD
assessment tools.

Results

Comments

Subjective/Self-reported Sleep Quality

Sunbul et al. (56),
2014

Self-Report
questionnaire

Kim et al, 2015
(17)

Self-Report
(PSQI)

baPWV

PWV cm/sec.: [Sleep Deprivation (SD) vs
Regular Sleep (RS)]:
5.33±0.46 vs 5.15±0.26; p = 0.001
Augmentation index (AIx) s: [SD vs RS ]:
20.5±11.9 vs 26.0±8.4%; p = 0.008

Turkish population.

baPWV

PWV cm/sec: [Good vs. Poor sleep quality]
95% CI Adj b:
Men: 0.0 (Ref.) vs. 7.6 (1.2 to 13.9)
Women: 0.0 (Ref.) vs. 2.7 (−5.3 to 10.7)

Poor subjective sleep quality was associated with
increase in PWV in men
only in adjusted model.

PWV cm/s: [Among sleep quality groups]
(95% CI) Adj o
Good: 1523 (1500, 1547)
Average: 1570 (1533, 1606)
Poor: 1604 (1547, 1661); p ＜ 0.05

Poor sleep quality associated with higher PWV

Osonoi et al,
2015 (68)

Self-Report
(PSQI)

baPWV

Yamaki et al.
2015

Self-Report
(PSQI)

ABI

PSQI sleep quality score and ABI (rho =
−0.31); p ＜ 0.005

Lower the ABI, more the
arterial stiffness.

Objective Sleep Quality
Not even a single study have described the association of objective sleep Quality with Arterial Stiffness.
b Adjusted

for age, sex, study center, year of visit, education, marital status, depression, smoking status, alcohol consumption, physical activity, body
mass index, fasting glucose, systolic blood pressure, diastolic blood pressure, height, and heart rate.
o Adjusted for age, gender, BMI, morningness eveningness questionnaire, Beck Depression inventory, energy intake, alcohol intake, current smoking, physical activity, systolic BP, HbA1c, total cholesterol, HDL-cholesterol, triglyceride and sleep duration

dardized duration, some studies used 6 hours as reference sleep duration, some used 7 hours, some used 8
hours and some studies even used 6 – 8 hours as reference sleep duration. The assessment of subjective and
objective sleep quality was also different among the
studies used in this review. Some studies used insomnia vs. non-insomnia, some used shift vs non-shift
work, some used fragmentation index and/or arousal
index and/or REM/Non-REM sleep to assess the sleep
quality. A few studies that examined both subjective
and objective sleep parameters demonstrated different
outcomes depending on the nature of the predictor
variable used in their analysis (subjective versus objective).
Some of the studies included in our review are of
questionable methodological quality, which may be
another source of observation bias. The population
discussed in this systematic review ranges from 20 to
87 years and due to heterogeneous nature of these
studies we could not conclude what age groups were
at more risk of subclinical CVD based on their sleep
disturbances, thus more focused studies directed to
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specific age group are needed to further clarify this
concern. Furthermore, ethnic-specific variations in
sleep parameters and association with subclinical CVD
have not been discussed and compared in these studies
and thus question the need of further studies discussing the comparison of subclinical CVD burden in the
multi-ethnic populations. Another concern is that
most of the studies used in this review are cross sectional and as a result, causality cannot be determined.
Our findings show the need for follow up studies to
assess the rapid progression of subclinical CVD with
sleep disturbances. This will further clarify the association of sleep parameters with an increased subclinical
and clinical CVD burden. Finally, the implications of
the associations demonstrated in our review are
unclear. Should individuals with sleep disturbances be
considered candidates for subclinical CVD screening?
Most sleep disturbance treatment focuses on lifestyle
modification, which is beneficial for CVD. However,
in scenarios where one is found to have these findings,
should one be a candidate for aggressive preventive
pharmacotherapy such as Statins ? What will be the
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Table 6. Snapshot of association of “Non-Invasive Subclinical CVD assessment tools” with Sleep Duration and Sleep Quality
Non-Invasive
Subclinical CVD
assessment tools

Subjective sleep duration Vs Reference
Sleep Duration (6-8 hrs)

Objective sleep duration Vs Reference
Sleep Duration (6-8 hrs)

Subjective sleep
quality

Objective sleep
quality

Short subjective
sleep duration

Long subjective
sleep duration

Short objective
sleep duration

Long objective
sleep duration

CAC

Association
present

Association
present

Association
variable

Association
variable

Association
variable

Association
variable

CIMT

Association
present

Association
present

Association
present

Association
variable

Association
variable

Association
present

Endothelial
function

Association
variable

Association
variable

Lack of
association

Lack of
association

Association
present

Association
present

Arterial stiffness

Association
variable

Association
present

NR

NR

Association
present

NR

NR = Not reported.
Association variable: In this review some studies showed positive and some studies showed negative and some studies showed lack of an association
between sleep duration and sleep quality with Non-Invasive Subclinical CVD assessment tools.
Association present: In this review most of the studies showed presence of an association between sleep duration and sleep quality with No-Invasive
Subclinical CVD assessment tools.
Lack of association: In this review most of the studies showed lack of an association between sleep duration and sleep quality with Non-Invasive
Subclinical CVD assessment tools.
Subjective Sleep Quality: Expressed as PSQI, good vs PSQI bad sleep quality, insomnia vs non-insomnia, shift vs. non-shift work, arousal index,
sleep efficiency (%), REM/Non-REM sleep.

most cost effective method for screening ? Unfortunately, no consensus exists in this specific area.
Conclusion
In conclusion, based on our systematic review,
individuals with sleep disturbances, both quantitative
and qualitative, have an accelerated subclinical CVD
burden in the form of augmented Coronary Artery
Calcium (CAC), increased Carotid Intima Media
Thickness (CIMT), impaired endothelial function,
and augmented arterial stiffness. Table 6 provides a
snapshot of association of non-Invasive Subclinical
CVD assessment tools with sleep duration and sleep
quality. These findings suggest that association
between sleep disturbances and increased CVD risk is
exemplified by early changes in sub-clinical CVD status. Important issues that need further exploration
include the public awareness of regular sleep habits,
and potential consequences of compromised sleep
duration and quality in terms of causing hypertension,
high cholesterol and risk of diabetes. There is a need
to identify appropriate screening and treatment strategies across different group of populations with sleep
disturbances and whether these preventive approaches
can slow progression of sub-clinical CVD and reduction in clinical events. Comprehensive studies aimed
at answering these key questions can facilitate generation of information to guide preventive efforts in this

population.
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